+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Cracked Ganoderma Lucidum Spore Powder Capsules Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6081349
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Ganoderma lucidum spore powder capsules have emerged as a focal point for health-conscious consumers, blending traditional wisdom with modern convenience. These capsules encapsulate the bioactive compounds of Ganoderma lucidum spores, offering a standardized, easily dosed format that addresses both efficacy and consumer preference. In recent years, innovations in extraction and cracking technologies have significantly improved the bioavailability of spore constituents, driving heightened interest among nutraceutical developers and end users alike. As regulatory scrutiny intensifies and global trade dynamics evolve, stakeholders must navigate shifting policies, supply-chain complexities and competitive pressures.

This executive summary provides a concise yet comprehensive examination of the key factors shaping the cracked Ganoderma lucidum spore powder capsules market. Beginning with a contextual overview, it then explores transformative industry trends, the impact of evolving tariff regimes, segmentation analyses, regional performance patterns and leading competitors. Finally, it offers actionable recommendations for decision-makers seeking to capitalize on growth opportunities while mitigating emerging risks. By synthesizing the most recent data and strategic insights, this report empowers industry leaders to align innovation, operations and market engagement strategies with the rapidly evolving landscape.

Transformative Shifts Defining Industry Dynamics

Transformative Shifts in the Landscape

Over the last decade, advancements in spore cracking and encapsulation processes have redefined product quality benchmarks, enabling higher concentrations of triterpenoids and polysaccharides. These innovations underpin a broader shift toward evidence-based positioning, in which brands emphasize clinically validated benefits such as immune modulation, antioxidant support and cognitive wellness. Concurrently, growing consumer demand for clean-label supplements has prompted manufacturers to adopt solvent-free extraction methods and third-party ingredient verification protocols.

Digital commerce platforms and subscription-based models have also disrupted traditional distribution channels. E-commerce marketplaces now account for a substantial share of sales, empowering niche brands to reach global audiences efficiently. Meanwhile, strategic partnerships with healthcare practitioners and integrative medicine clinics have elevated product legitimacy, creating dual-access pathways through both retail and professional channels.

Regulatory frameworks have kept pace with innovation, with key markets implementing rigorous standards for spore authentication and contaminant thresholds. As a result, quality assurance and traceability have emerged as critical differentiators. Looking ahead, the convergence of advanced analytics, biotechnology-driven extraction and consumer-centric marketing is poised to drive the next wave of transformation, reshaping value propositions and competitive dynamics simultaneously.

Assessing the 2025 US Tariff Revisions and Their Effects

Cumulative Impact of United States Tariffs 2025

The introduction of revised tariff schedules in early 2025 has altered the cost structure for imports of raw Ganoderma lucidum spores, affecting both domestic processors and finished goods distributors. Tariffs levied on unprocessed spores and intermediary extracts have increased input costs by an estimated 8 to 12 percent, compelling manufacturers to reassess sourcing strategies and pass through a portion of these costs to end users.

In response, several industry participants have diversified supply chains, forging direct partnerships with cultivators in regions less affected by punitive duties. Meanwhile, forward-looking companies have leveraged bonded warehousing and tariff optimization programs to mitigate short-term cost pressures. Some players have also intensified investments in domestic cultivation facilities, aiming to reduce exposure to cross-border levies and strengthen supply resilience.

Furthermore, the new tariff environment has spurred consolidation among smaller suppliers unable to absorb margin compression. Larger firms have capitalized on this trend, expanding their procurement networks and reinforcing economies of scale. Ultimately, the 2025 tariffs have not only reshaped cost dynamics but also accelerated strategic realignments across the value chain, reinforcing the importance of agility and regulatory foresight.

Segmentation Analysis by Form: Capsules vs. Powder

Key Segmentation Insights

An analysis based on form reveals two primary delivery options: capsule and powder. Capsules remain the preferred choice for consumers seeking convenience, consistent dosing and portability, driving leading brands to prioritize encapsulation technologies that protect bioactive integrity. Powder, by contrast, appeals to those who favor flexible dosing, blend customization and cost efficiency, making it a staple ingredient for beverage formulations and functional food applications.

In the capsule segment, innovations such as vegan-friendly shells and delayed-release coatings have elevated consumer perception and facilitated premium pricing. In parallel, powder providers have responded to growing interest in on-the-go wellness shots by offering single-serve sachets with improved solubility and taste masking. Despite divergent end-use scenarios, both forms share a common imperative: demonstrating bioavailability through third-party testing and clinical studies. This dual approach ensures that brands maintain credibility while catering to distinct user preferences.

Regional Performance Patterns and Drivers

Key Regional Insights

Within the Americas, strong consumer awareness of mushroom-derived supplements has fueled robust growth in both brick-and-mortar and online channels. Partnerships with integrative health clinics and dietary supplement retailers have further bolstered market penetration. In Europe, Middle East & Africa, stringent regulatory requirements and a preference for natural health solutions have created opportunities for premium, contaminant-tested offerings, although price sensitivity remains a consideration in certain markets.

The Asia-Pacific region, home to traditional Ganoderma lucidum cultivation, leads in raw material production and boasts established distribution networks. Rising disposable incomes and government initiatives supporting traditional medicine have driven increased domestic consumption, while export-oriented facilities benefit from economies of scale. Across all regions, cross-border e-commerce and standardized quality certifications are becoming critical success factors, enabling brands to navigate complex trade regulations and scale internationally.

Leading Competitors and Their Strategic Differentiators

Key Companies Insights

A competitive landscape defined by both global giants and specialized innovators has emerged. Aloha Medicinals Inc. and DXN Holdings Berhad leverage vertically integrated supply chains to ensure consistent raw material quality. Fungi Perfecti, LLC. and Ganoderma USA, Inc. differentiate through proprietary extraction technologies that maximize active compound yields. Hawlik Gesundheitsprodukte GmbH and Hokkaido Reishi Co., Ltd. combine longstanding reputations in natural products with rigorous European safety standards to serve discerning markets.

At the same time, Mushroom Science, LLC and Nature's Bounty Co. prioritize scientific collaborations and consumer education initiatives to reinforce product efficacy claims. Nature’s Way Products, LLC and New Chapter, Inc. have capitalized on omnichannel distribution strategies, blending retail partnerships with online subscriptions. NOW Health Group, Inc. and Organo Gold Enterprises, Inc. drive innovation in functional beverage integrations, while ReishiKing Co., Ltd. and Swanson Health Products, Inc. focus on cost-effective formulations that retain high bioactive concentrations. Collectively, these companies illustrate the interplay of scale, specialization and branding in defining competitive advantage.

Strategic Imperatives for Maximizing Market Opportunities

Actionable Recommendations for Industry Leaders

First, prioritize end-to-end traceability by implementing blockchain or digital ledger systems to authenticate spore origins and processing parameters. This investment will not only ensure compliance with evolving regulations but also reinforce brand trust among informed consumers. Second, broaden product portfolios by exploring hybrid formulations that combine cracked spore powder with complementary actives such as adaptogenic botanicals or nootropics, thereby creating differentiated offerings with multi-dimensional health benefits.

Third, optimize supply-chain resilience through a dual-sourcing approach: secure strategic partnerships with established cultivators in low-tariff jurisdictions while simultaneously developing local cultivation or extraction capabilities. Fourth, enhance market access via targeted omnichannel strategies that integrate direct-to-consumer platforms, professional-channel partnerships and selective retail alliances. Finally, commit to rigorous clinical validations and transparent communication of study outcomes, as evidence-based marketing will drive long-term consumer loyalty and justify premium positioning.

Synthesizing Insights and Future Outlook

Conclusion

The cracked Ganoderma lucidum spore powder capsule market stands at the intersection of traditional wisdom and cutting-edge innovation. Recent improvements in extraction and encapsulation have unlocked new potential for consumer engagement, while shifting regulatory frameworks and tariff landscapes demand strategic agility. Segmentation by form continues to shape product development priorities, as businesses balance the convenience of capsules against the versatility of powders.

Regionally, diverse dynamics-ranging from robust e-commerce growth in the Americas to heritage cultivation strengths in Asia-Pacific-underscore the importance of tailored market approaches. The competitive arena features a mix of vertically integrated powerhouses and nimble specialists, each capitalizing on distinct capabilities to differentiate their offerings. Moving forward, companies that adopt transparent supply chains, invest in clinical validation and execute integrated distribution strategies will be best positioned to capture sustainable value in this evolving landscape.

Market Segmentation & Coverage

This research report categorizes the Cracked Ganoderma Lucidum Spore Powder Capsules Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Capsule
  • Powder

This research report categorizes the Cracked Ganoderma Lucidum Spore Powder Capsules Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Cracked Ganoderma Lucidum Spore Powder Capsules Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Aloha Medicinals Inc.
  • DXN Holdings Berhad
  • Fungi Perfecti, LLC.
  • Ganoderma USA, Inc.
  • Hawlik Gesundheitsprodukte GmbH
  • Hokkaido Reishi Co., Ltd.
  • Mushroom Science, LLC
  • Nature's Bounty Co.
  • Nature's Way Products, LLC
  • New Chapter, Inc.
  • NOW Health Group, Inc.
  • Organo Gold Enterprises, Inc.
  • ReishiKing Co., Ltd.
  • Swanson Health Products, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cracked Ganoderma Lucidum Spore Powder Capsules Market, by Form
8.1. Introduction
8.2. Capsule
8.3. Powder
9. Americas Cracked Ganoderma Lucidum Spore Powder Capsules Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Cracked Ganoderma Lucidum Spore Powder Capsules Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Cracked Ganoderma Lucidum Spore Powder Capsules Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2024
12.2. FPNV Positioning Matrix, 2024
12.3. Competitive Analysis
12.3.1. Aloha Medicinals Inc.
12.3.2. DXN Holdings Berhad
12.3.3. Fungi Perfecti, LLC.
12.3.4. Ganoderma USA, Inc.
12.3.5. Hawlik Gesundheitsprodukte GmbH
12.3.6. Hokkaido Reishi Co., Ltd.
12.3.7. Mushroom Science, LLC
12.3.8. Nature's Bounty Co.
12.3.9. Nature's Way Products, LLC
12.3.10. New Chapter, Inc.
12.3.11. NOW Health Group, Inc.
12.3.12. Organo Gold Enterprises, Inc.
12.3.13. ReishiKing Co., Ltd.
12.3.14. Swanson Health Products, Inc.
13. ResearchAI
14. ResearchStatistics
15. ResearchContacts
16. ResearchArticles
17. Appendix
List of Figures
FIGURE 1. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET MULTI-CURRENCY
FIGURE 2. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET MULTI-LANGUAGE
FIGURE 3. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. AMERICAS CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 10. AMERICAS CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 12. UNITED STATES CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. ASIA-PACIFIC CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. ASIA-PACIFIC CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 18. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. AMERICAS CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 10. AMERICAS CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 11. ARGENTINA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 12. BRAZIL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 13. CANADA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 14. MEXICO CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. ASIA-PACIFIC CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 18. ASIA-PACIFIC CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 19. AUSTRALIA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 20. CHINA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 21. INDIA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 22. INDONESIA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 23. JAPAN CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 24. MALAYSIA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 25. PHILIPPINES CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 26. SINGAPORE CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 27. SOUTH KOREA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 28. TAIWAN CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 29. THAILAND CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 30. VIETNAM CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. DENMARK CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 34. EGYPT CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 35. FINLAND CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 36. FRANCE CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 37. GERMANY CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 38. ISRAEL CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 39. ITALY CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 40. NETHERLANDS CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 41. NIGERIA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 42. NORWAY CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 43. POLAND CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 44. QATAR CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 45. RUSSIA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 46. SAUDI ARABIA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 47. SOUTH AFRICA CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 48. SPAIN CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 49. SWEDEN CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 50. SWITZERLAND CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 51. TURKEY CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 52. UNITED ARAB EMIRATES CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 53. UNITED KINGDOM CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 54. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET SHARE, BY KEY PLAYER, 2024
TABLE 55. CRACKED GANODERMA LUCIDUM SPORE POWDER CAPSULES MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

  • Aloha Medicinals Inc.
  • DXN Holdings Berhad
  • Fungi Perfecti, LLC.
  • Ganoderma USA, Inc.
  • Hawlik Gesundheitsprodukte GmbH
  • Hokkaido Reishi Co., Ltd.
  • Mushroom Science, LLC
  • Nature's Bounty Co.
  • Nature's Way Products, LLC
  • New Chapter, Inc.
  • NOW Health Group, Inc.
  • Organo Gold Enterprises, Inc.
  • ReishiKing Co., Ltd.
  • Swanson Health Products, Inc.

Methodology

Loading
LOADING...